DK1151297T3 - Fremgangsmåde til forøgelse af bindingsinteraktioner mellem medlemmer af specifikke bindingspar - Google Patents

Fremgangsmåde til forøgelse af bindingsinteraktioner mellem medlemmer af specifikke bindingspar

Info

Publication number
DK1151297T3
DK1151297T3 DK00905755.5T DK00905755T DK1151297T3 DK 1151297 T3 DK1151297 T3 DK 1151297T3 DK 00905755 T DK00905755 T DK 00905755T DK 1151297 T3 DK1151297 T3 DK 1151297T3
Authority
DK
Denmark
Prior art keywords
members
binding
reactions
specific binding
pairs
Prior art date
Application number
DK00905755.5T
Other languages
English (en)
Inventor
Galla Chandra Rao
Leon W M M Terstappen
Paul A Liberti
Original Assignee
Veridex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex Llc filed Critical Veridex Llc
Application granted granted Critical
Publication of DK1151297T3 publication Critical patent/DK1151297T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Reinforced Plastic Materials (AREA)
  • Die Bonding (AREA)
  • Pressure Welding/Diffusion-Bonding (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Joining Of Building Structures In Genera (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00905755.5T 1999-01-29 2000-01-27 Fremgangsmåde til forøgelse af bindingsinteraktioner mellem medlemmer af specifikke bindingspar DK1151297T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/240,939 US6551843B1 (en) 1999-01-29 1999-01-29 Methods for enhancing binding interactions between members of specific binding pairs
PCT/US2000/002034 WO2000045169A1 (en) 1999-01-29 2000-01-27 Methods for enhancing binding interactions between members of specific binding pairs

Publications (1)

Publication Number Publication Date
DK1151297T3 true DK1151297T3 (da) 2010-03-01

Family

ID=22908555

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00905755.5T DK1151297T3 (da) 1999-01-29 2000-01-27 Fremgangsmåde til forøgelse af bindingsinteraktioner mellem medlemmer af specifikke bindingspar

Country Status (11)

Country Link
US (1) US6551843B1 (da)
EP (1) EP1151297B1 (da)
JP (2) JP2002535677A (da)
AT (1) ATE449333T1 (da)
AU (1) AU2738900A (da)
CA (1) CA2359664A1 (da)
DE (1) DE60043335D1 (da)
DK (1) DK1151297T3 (da)
ES (1) ES2335080T3 (da)
PT (1) PT1151297E (da)
WO (1) WO2000045169A1 (da)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282350B2 (en) 1998-02-12 2007-10-16 Immunivest Corporation Labeled cell sets for use as functional controls in rare cell detection assays
US6623982B1 (en) * 1999-07-12 2003-09-23 Immunivest Corporation Increased separation efficiency via controlled aggregation of magnetic nanoparticles
AU6345600A (en) * 2000-07-14 2002-01-30 Immunivest Corp Increased separation efficiency via controlled aggregation of magnetic nanoparticles
US7863012B2 (en) * 2004-02-17 2011-01-04 Veridex, Llc Analysis of circulating tumor cells, fragments, and debris
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
US8980568B2 (en) 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
EP1474772A4 (en) 2002-02-14 2005-11-09 Immunivest Corp METHODS AND ALGORITHMS FOR COUNTING CELLS IN A SMALL CYTOMETER
US7764821B2 (en) 2002-02-14 2010-07-27 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
EP1597353B1 (en) 2003-02-27 2010-11-24 Veridex, LLC CIRCULATING TUMOR CELLS (CTC's): EARLY ASSESSMENT OF TIME TO PROGRESSION SURVIVAL AND RESPONSE TO THERAPY IN METASTATIC CANCER PATIENTS
US20060035242A1 (en) 2004-08-13 2006-02-16 Michelitsch Melissa D Prion-specific peptide reagents
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
US8189899B2 (en) 2004-07-30 2012-05-29 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
ES2457755T3 (es) 2004-08-17 2014-04-29 Veridex, Llc Un dispositivo de obtención de imágenes de diagnóstico para análisis de células raras circulantes
WO2006076683A2 (en) * 2005-01-13 2006-07-20 Novartis Vaccines And Diagnostics Inc. Isolation and detection of pathogenic prions
MX2007008497A (es) * 2005-01-13 2007-09-14 Novartis Vaccines & Diagnostic Ensayos inmunosorbentes enlazados a enzimas usando reactivos de peptidos especificos de prion.
US7777885B2 (en) * 2005-08-17 2010-08-17 Veridex, Llc Diagnostic imaging device for the analysis of circulating rare cells
KR20080048527A (ko) 2005-09-09 2008-06-02 노파르티스 아게 프리온-특이적 펩토이드 시약
US8337755B2 (en) * 2006-03-13 2012-12-25 Veridex, Llc Operator independent programmable sample preparation and analysis system
CN101583722A (zh) 2006-07-14 2009-11-18 阿维瓦生物科学股份有限公司 从生物学样品检测稀有细胞的方法和组合物
US8003314B2 (en) 2007-04-16 2011-08-23 Diagnostic Hybrids, Inc. Methods for direct fluorescent antibody virus detection in liquids
US8110101B2 (en) * 2007-08-30 2012-02-07 Veridex, Llc Method and apparatus for imaging target components in a biological sample using permanent magnets
US20090061456A1 (en) * 2007-08-30 2009-03-05 Allard William J Method for predicting progression free and overall survival at each follow-up time point during therapy of metastatic breast cancer patients using circulating tumor cells
US7828968B2 (en) 2007-08-30 2010-11-09 Veridex, Llc Method and apparatus for imaging target components in a biological sample using permanent magnets
US20090117532A1 (en) * 2007-11-01 2009-05-07 Doyle Gerald V Pre-clinical method for monitoring serial changes in circulating breast cancer cells in mice
CN101878429B (zh) * 2007-11-27 2015-05-20 维里德克斯有限责任公司 血液中循环黑素瘤细胞的自动化计数和表征
US8071395B2 (en) * 2007-12-12 2011-12-06 The Board Of Trustees Of The Leland Stanford Junior University Methods and apparatus for magnetic separation of cells
US20090191535A1 (en) * 2007-12-22 2009-07-30 Mark Carle Connelly Method of assessing metastatic carcinomas from circulating endothelial cells and disseminated tumor cells
KR101384142B1 (ko) * 2007-12-28 2014-04-14 삼성디스플레이 주식회사 표시기판, 이의 제조방법 및 이를 갖는 표시장치
US9078932B2 (en) * 2008-02-04 2015-07-14 Emmetrope, Inc. Magnetic cells for localizing delivery and tissue repair
CA2721982A1 (en) * 2008-04-30 2009-11-05 Novartis Ag Assay for pathogenic conformers
DK2338052T3 (da) * 2008-10-16 2020-02-17 Koninklijke Philips Nv Fremgangsmåde og anordning til bestemmelse af mængden af magnetisk-mærkede målkomponenter
WO2011109440A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
WO2010068812A1 (en) 2008-12-10 2010-06-17 Abqmr, Inc. Nuclear magnetic resonance apparatus, methods and associated technology
US20120077246A1 (en) * 2009-04-24 2012-03-29 The Board Of Trustees Of The University Of Illinoi Methods and Devices for Capturing Circulating Tumor Cells
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
EP2496947A1 (en) 2009-11-04 2012-09-12 Novartis AG Positively charged species as binding reagents in the separation of protein aggregates from monomers
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
KR101212029B1 (ko) * 2011-12-20 2012-12-13 한국기초과학지원연구원 화합물 결합단백질 검출 방법
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
EP3114484A4 (en) 2014-03-07 2017-08-30 The Board of Trustees of the University of Illionis Biomimetic microfluid device for capturing circulating tumor cells
WO2016183032A1 (en) 2015-05-08 2016-11-17 Biomagnetic Solutions Llc Apparatus and method for immunomagnetic cell separation
JP6754345B2 (ja) * 2016-09-30 2020-09-09 アークレイ株式会社 粒子の磁気標識方法及び標識装置
US11249077B2 (en) 2016-09-30 2022-02-15 Arkray, Inc. Method for magnetically labeling particles and labeling apparatus
WO2019216887A1 (en) 2018-05-08 2019-11-14 Biomagnetic Solutions Llc A rigid chamber for cell separation from a flexible disposable bag
EP3693739A1 (de) 2019-02-06 2020-08-12 Stefan Schreier Verfahren und vorrichtung zur isolierung von gewünschten zellen aus einer probe nicht-magnetischer biologischer materialien

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018886A (en) 1975-07-01 1977-04-19 General Electric Company Diagnostic method and device employing protein-coated magnetic particles
US3970518A (en) 1975-07-01 1976-07-20 General Electric Company Magnetic separation of biological particles
US4267234A (en) 1978-03-17 1981-05-12 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US4375407A (en) 1981-06-22 1983-03-01 The Franklin Institute High gradient magnetic separation device
US4554088A (en) 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
US4795698A (en) 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US4847193A (en) * 1987-06-18 1989-07-11 Gene-Trak Systems Signal amplification in an assay employing a piezoelectric oscillator
US5215926A (en) 1988-06-03 1993-06-01 Cellpro, Inc. Procedure for designing efficient affinity cell separation processes
US5186827A (en) 1991-03-25 1993-02-16 Immunicon Corporation Apparatus for magnetic separation featuring external magnetic means
WO1996007101A1 (en) * 1994-08-31 1996-03-07 First Medical, Inc. Quantitative assays employing magnetizable particles for rate enhancement
JP3962789B2 (ja) 1995-02-21 2007-08-22 ダブリュー． シディキー，イクバール 磁性粒子を利用した混合／分離装置及びその方法
JPH08313539A (ja) * 1995-05-16 1996-11-29 Nittec Co Ltd 容器およびこの容器を用いた液体撹拌・洗浄・磁性体微粒子捕集方法並びに該容器を用いた免疫化学検査装置
EP0920627B1 (en) * 1996-06-07 2004-05-12 Immunivest Corporation Magnetic separation employing external and internal gradients
EP1362918B8 (en) * 1998-07-01 2009-08-05 Takara Bio Inc. Gene transfer methods with retroviruses

Also Published As

Publication number Publication date
AU2738900A (en) 2000-08-18
ATE449333T1 (de) 2009-12-15
EP1151297B1 (en) 2009-11-18
US6551843B1 (en) 2003-04-22
JP5442544B2 (ja) 2014-03-12
PT1151297E (pt) 2010-01-20
WO2000045169A1 (en) 2000-08-03
ES2335080T3 (es) 2010-03-22
JP2010261963A (ja) 2010-11-18
JP2002535677A (ja) 2002-10-22
DE60043335D1 (de) 2009-12-31
EP1151297A1 (en) 2001-11-07
WO2000045169A9 (en) 2001-07-26
CA2359664A1 (en) 2000-08-03
EP1151297A4 (en) 2003-04-09

Similar Documents

Publication Publication Date Title
DK1151297T3 (da) Fremgangsmåde til forøgelse af bindingsinteraktioner mellem medlemmer af specifikke bindingspar
ATE431684T1 (de) Zellulares funknetz mit wiedergebrauch von frequenzen
DK1042496T3 (da) Fremgangsmåde til enzymatisk fremstilling af homogentisat
DE69940301D1 (de) Zeitaufteilung von Kommunikationsressourcen in zellularen Kommunikationssystemen
EA199801031A1 (ru) Ингибиторы протеинфарнезилтрансферазы
MXPA03010746A (es) Conmutacion en sistema de comunicacion celular.
BR9713436B1 (pt) processo para melhorar o desempenho de um sistema de comunicação móvel, e, sistema de comunicação móvel.
ATE261456T1 (de) Thermisch härtbare polymerdispersion
ATE537264T1 (de) Verfahren und zusammensetzungen für die gerichtete mikrowellenchemiie
DE60029230D1 (de) Dipeptidyl-peptidasen
DE60042209D1 (de) Enzymatische synthese von deoxyribonucleotiden
WO2002030465A3 (en) Compositions that inhibit proliferation of cancer cells
BR0200574B8 (pt) Processo para hidroprocessar alimentação de hidrocarboneto.
ATE344321T1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
DE60113135D1 (de) Blindbefestiger
DE69923676D1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
ATE228671T1 (de) Prozesssteuerung
FI980716A0 (fi) Arrangemang i samband med en hydraulvaetskedriven slaganordning, saosom t.ex. i en krossanordning
AU2003233579A8 (en) Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers
ATE408697T1 (de) Enzymatische umwandlung von gdp-mannose in gdp- fucose
TR200400184T2 (tr) Herbisidal bileşiklere tolerans veren DNA molekülleri
TR200103248T2 (tr) Hidrojen,su ile işlemden geçirilmiş hidrokarbonlar ve elektrik üretilmesine yönelik olarak hidrokarbonun su ile dönüşütürülmesi yöntemi
TR200000624T2 (tr) Bir enzimin etkinliğinin arttırılması ile ilgili bir yöntem.
ATE349866T1 (de) Verfahren und system zum abfragen von merkmalen in einem zellularen kommunikationssystem
WO2002017900A3 (en) Modulators of us28 (chemokines) for treating cytomegalovirus infections